间充质干细胞
脂肪生成
脂肪组织
骨髓
软骨发生
干细胞
细胞生物学
细胞分化
脐带
间充质
化学
生物
免疫学
生物化学
基因
作者
C. K. Rebelatto,Alessandra Melo de Aguiar,M. P. Moretão,Alexandra Cristina Senegaglia,Paula Hansen Suss,Fabiane Barchiki,Joaquim Miguel Oliveira,J. Martins,Crisciele Kuligovski,Fizzah Mansur,A. Christofis,Vivian Ferreira do Amaral,Paulo Roberto Slud Brofman,Samuel Goldenberg,Lia S. Nakao,Alejandro Correa
摘要
Mesenchymal stem cells (MSCs) have been investigated as promising candidates for use in new cell-based therapeutic strategies such as mesenchyme-derived tissue repair. MSCs are easily isolated from adult tissues and are not ethically restricted. MSC-related literature, however, is conflicting in relation to MSC differentiation potential and molecular markers. Here we compared MSCs isolated from bone marrow (BM), umbilical cord blood (UCB), and adipose tissue (AT). The isolation efficiency for both BM and AT was 100%, but that from UCB was only 30%. MSCs from these tissues are morphologically and immunophenotypically similar although their differentiation diverges. Differentiation to osteoblasts and chondroblasts was similar among MSCs from all sources, as analyzed by cytochemistry. Adipogenic differentiation showed that UCB-derived MSCs produced few and small lipid vacuoles in contrast to those of BM-derived MSCs and AT-derived stem cells (ADSCs) (arbitrary differentiation values of 245.57 +/- 943 and 243.89 +/- 145.52 mum(2) per nucleus, respectively). The mean area occupied by individual lipid droplets was 7.37 mum(2) for BM-derived MSCs and 2.36 mum(2) for ADSCs, a finding indicating more mature adipocytes in BM-derived MSCs than in treated cultures of ADSCs. We analyzed FAPB4, ALP, and type II collagen gene expression by quantitative polymerase chain reaction to confirm adipogenic, osteogenic, and chondrogenic differentiation, respectively. Results showed that all three sources presented a similar capacity for chondrogenic and osteogenic differentiation and they differed in their adipogenic potential. Therefore, it may be crucial to predetermine the most appropriate MSC source for future clinical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI